SEARCH Articles Figures Tables Bcr-Abl-tyrosine kinase inhibitor Bisubstrate tyrosine kinase inhibitors Breast Cancer Human Epidermal Growth Factor Tyrosine Kinase Inhibitors Cancer chemotherapy tyrosine kinase inhibitors Cancer, treatment using tyrosine kinase inhibitors Cancer, treatment using tyrosine kinase receptor inhibitors Chemotherapy tyrosine kinase inhibitors EFGR tyrosine kinase inhibitor EGFR tyrosine kinase inhibitor Imidazoles tyrosine kinase inhibitor Inhibitors, spleen tyrosine kinase Multiple tyrosine kinase inhibitor Natural tyrosine kinase inhibitor Of tyrosine kinase inhibitor Protein tyrosine phosphatase IB inhibitor Protein tyrosine phosphatase inhibitors Protein-tyrosine Kinase Inhibitors Receptor tyrosine kinase inhibitor Tie2 tyrosine kinase inhibitor Tyrosine hydroxylase inhibitor Tyrosine hydroxylase inhibitors administration Tyrosine kinase inhibitor therapy Tyrosine kinase inhibitors Tyrosine kinase inhibitors Philadelphia chromosome Tyrosine kinase inhibitors biological activity Tyrosine kinase inhibitors imatinib mesylate Tyrosine kinase inhibitors in cancer therapy Tyrosine kinase inhibitors molecular modeling Tyrosine kinase plant-derived inhibitors Tyrosine phosphatase inhibitors Tyrosine-specific kinase inhibitor VEGF receptor tyrosine kinase inhibitors Vascular endothelial growth factor tyrosine kinase inhibitors